TD OSTEOPATHY LIMITED
Opportunity 70/100 (strong), bankability 65/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: low (52/100)Sparse data coverage. Treat AI-generated outputs as preliminary. Manual diligence essential.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Recent activity
Corporate timeline (3 events)Click to expand
- 2024-08-29🏢Company incorporatedAs TD OSTEOPATHY LIMITED
- 2024-08-29➕DUCK, Thomas James appointeddirector
- 2024-08-29📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Young company: Only 1.7 years old — management layer unlikely to be developed.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Thomas James Duck Individual · Australian · DOB 10/1995 · age 31 | 75–100% | 75–100% | 75-100% shares · 75-100% voting | 29/08/2024 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · G postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| THE INVISIBLE HEARING CLINIC LTD→ SC393924 · est 2011 · no financials extracted | — | — | — | — | 15y | — | — |
| THE MURE HALL COMPANY→ SC217179 · est 2001 · no financials extracted | — | — | — | — | 25y | — | — |
| THE ORAL SURGERY CLINIC LTD→ SC490909 · est 2014 · no financials extracted | — | — | — | — | 11y | — | — |
| THE ORIELLE CLINIC LTD→ SC859385 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| THE STOCKTON CLINIC LTD→ SC618882 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| TM AESTHETICS LTD→ SC718989 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| TRUE TOUCH CARE LTD→ SC848467 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| TULLOCHAN→ SC219319 · est 2001 · no financials extracted | — | — | — | — | 24y | — | — |
| UK & Z LTD→ SC732173 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| UREYES LTD→ SC595159 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| VITAL SPARK HEALTH LTD→ SC688233 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| VITALIS HEALTHCARE LIMITED→ SC255218 · est 2003 · no financials extracted | — | — | — | — | 22y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.